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I. Introduction
Pterygium is characterized by tissue remodelling, cellular proliferation, neovascularization, and inflammation [1] [2] . A stromal overgrowth of fibroblast and blood vessel is accompanied by an inflammatory cell infiltrate and abnormal extracellular matrix accumulation [3] [4] [5] [6] . Although several hypotheses have been associated with its etiology, its pathology still remains to be explained. Secretion of pro-inflammatory cytokines such as interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor (TNF)-secondary to chronic ultraviolet (UV) radiation is a widely recognized etiological factor in pathogenesis of this lesion [6] [7] . Among these, IL-1 plays an important role in the development process of pterygium [6] [7] . The vascular endothelial growth factor (VEGF), which is known to have a role in angiogenesis, has been shown to exhibit an increase in pterygium epithelium and vascular endothelium [8] [9] . VEGF is believed to be stimulated by a mediation of TNF-through UVB (ultraviolet B) induction [10] . Cyclosporine A (CsA) shows a selective effect against T-helper cells and prevents the synthesis and secretion of ILs. CsA has also been shown to block angiogenic factors induced by VEGF [11] [12] .Based on the above evidence and due to insufficient knowledge about the role of pre & postoperative use of topical Cyclosporine in cases of recurrent and vascularized pterygium, we studied the efficacy of topical Cyclosporine used pre & postoperatively on the recurrence of vascularized and recurrent pterygium post surgery.
II. Materials And Methods
This prospective interventional study included 100 eyes of 100 patients of vascularized and recurrent pterygium, who presented in the eye OPD of a Zonal Hospital. Patients who had pseudopterygium, previous history of herpes keratitis, ocular surface disorder or pregnancy were not included in the study. postoperatively. All the patients in both the groups were followed-up for recurrence (encroachment of conjunctiva ahead of limbus more than 1mm), any adverse effect and complications. The follow-up was on 1 st day, 06 weeks, 12 weeks and 06 months postoperatively. Sample size of 100 patients, 50 in each group was calculated after keeping confidence interval of 95% and was based on results of similar study [13] . The data was collected and put through statistical analysis using Chi square test.
III. Results
Our study included 100 eyes of 100 patients (50 eyes in each, Group A & B). All the patients were followed-up for 06 months. The mean age in Group A was 42.1 years and in Group B was 45.0 years. The gender distribution was also seen to be statistically not significant between two groups. No graft infection, scleral melting, epithelial defect or any other significant vision threatening complication was seen in any of the cases. Peroperatively difficulty in adherence of graft was seen in 02 eyes in Group A. Postoperatively lost graft and graft oedema was seen in 01 eye each in Group B. Retracted graft was seen in 01 eye each from Group A & B.
IV. Discussion
Conjunctival autograft surgery is generally regarded as the procedure of choice for the treatment of primary and recurrent pterygium, because of its efficacy and long term safety [14] . A free conjunctival graft harvested from the superior bulbar conjunctiva is sutured in place over the bare scleral defect. A combination of conjunctival autograft with low dose (0.2mg/ml) mitomycin C was shown in a prospective randomized comparative study by Frucht-Pery et al. [15] to have a significantly lower recurrence rate compared with conjunctival graft alone. Conjunctival autografts are associated with recurrence rates (ranging from 2 to 39%) that are comparable to recurrence occurring after using mitomycin C and beta-irradiation, without the attendant risk of sight threatening complications associated with mitomycin C [14] .
Fibrin glue (or Tisseel) has been used as an alternative to sutures for securing conjunctival grafts [16] [17] . Fibrin glue also provides a more uniform attachment of the graft to the scleral bed. Most cases performed with fibrin adhesive healed with minimal inflammation and there are only sporadic cases of graft dislodgement or loss. In a retrospective study, Koranyi et al. [17] demonstrated a pterygium recurrence rate of 5.3% with glue versus 13.5% with sutures. They suggested that immediate adherence of the graft and the lack of postoperative inflammation may inhibit fibroblast ingrowth and reduce recurrence. Our study showed recurrence rate in group A (6%) comparable to the above study. Bahar et al. [18] showed that the use of fibrin glue was associated with a significantly shorter operative time and greater patient acceptance compared with using sutures. We observed [19] . Tok et al. used cyclosporine following primary excision in primary pterygium cases, and observed the recurrence of 12.9% [13] , Aydin et al who used topical cyclosporine with conjunctival limbal autograft observed a recurrence of 3.4% [20] and Ozulken K et al observed a recurrence of 7.7% with cyclosporine [21] .
Our recurrence rate was 06% in the Cyclosporine group (Group A), which was more than the recurrence observed by Aydin et al. [20] (3.4%) but lower than that observed by Tok et al. [13] (12.9%). It may be higher than observed by Aydin et al because of the study population of only vascularized and recurrent pterygium, which is more prone for higher recurrence compared to primary pterygium.
Although the recurrence rate between the two groups was not statistically significant, we believe that topical Cyclosporine is safe and effective in reducing recurrence rates, however, there is a need for increasing the size of study population, which should also include cases of primary pterygium, and the follow-up time should also be atleast one year.
